Dec 08, 2015

BioIT World: GNS Healthcare Announces $10M Financing, MMRF Study Results

bioit-world-logoGNS Healthcare announced a $10M Series C financing round today. New investors in this round—Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP—join previous investors including Cambia Health Solutions, California’s Heritage Provider Network, and Japan’s Mitsui & Co. U.S. subsidiary (“Mitsui USA”).
GNS builds cloud-based big data solutions for precision medicine and population health. Earlier this week, the Multiple Myeloma Research Foundation (MMRF) announced preliminary results of a multi-year collaboration with GNS to speed the discovery of innovative treatments for patients with multiple myeloma. GNS used its patented causal machine learning and simulation platform, REFS (Reverse Engineering and Forward Simulation), to analyze data from the CoMMpass Interim Analysis 7 (IA7) dataset, which is composed of extensive clinical and genomic data for a population of almost 800 enrolled patients.
Read the full article here